Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery

被引:33
|
作者
Al Harakeh, Ayman B. [3 ]
Burkhamer, Kyle J. [2 ]
Kallies, Kara J. [2 ]
Mathiason, Michelle A. [2 ]
Kothari, Shanu N. [1 ]
机构
[1] Gundersen Lutheran Hlth Syst, Dept Gen Surg, La Crosse, WI 54601 USA
[2] Gundersen Lutheran Med Fdn, Dept Surg Res, La Crosse, WI USA
[3] Gundersen Lutheran Med Fdn, Dept Med Educ, La Crosse, WI USA
关键词
Laparoscopic gastric bypass; Insurance; Denial; Co-morbidities; Morbid obesity; GASTROESOPHAGEAL-REFLUX DISEASE; Y GASTRIC BYPASS; WEIGHT-LOSS; SURVIVAL; DENIALS; IMPACT;
D O I
10.1016/j.soard.2010.08.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients satisfying the National Institutes of Health criteria and deemed appropriate candidates often do not undergo bariatric surgery for insurance-related reasons. Our objective was to explore the natural history of these patients compared with that of those who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB). Methods: The medical records of the patients evaluated for LRYGB from 2001 to 2007 were retrospectively reviewed. The presence of co-morbidities was assessed at the initial evaluation and within a 3-year follow-up period for patients who had undergone LRYGB and those denied surgery. The statistical analysis included chi-square tests. Results: A total of 189 patients were in the denied cohort and 587 in the LRYGB cohort. The age, gender, and body mass index were similar between the 2 cohorts at the initial evaluation. The percentage of patients with a diagnosis of a co-morbidity in the denied and LRYGB cohorts at the initial evaluation was 20% and 25% with diabetes mellitus, 51% and 43% with hypertension, 20% and 22% with obstructive sleep apnea, 34% and 24% with lipid disorders, and 62% and 49% with gastroesophageal reflux disease, respectively. The body mass index at the initial evaluation and during follow-up was 47.3 and 46.8 kg/m(2) in the denied cohort (n = 165, P = .236) and 48.5 and 30.5 kg/m(2) in the LRYGB cohort (n = 544, P < .001), respectively. During the follow-up period, a greater incidence of new-onset diabetes (P < .001), hypertension (P < .001), obstructive sleep apnea (P < .001), gastroesophageal reflux disease (P < .001), and lipid disorders (P < .001) was observed in the denied cohort. Conclusion: Patients denied LRYGB had a greater incidence of new co-morbidities diagnosed within a short follow-up period, without a significant change in their body mass index. (Surg Obes Relat Dis 2010;6:591-596.) (C) 2010 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 50 条
  • [1] Bariatric surgery for morbid obesity - A cure for metabolic syndrome?
    Kini, Subhash
    Herron, Daniel M.
    Yanagisawa, Robert T.
    MEDICAL CLINICS OF NORTH AMERICA, 2007, 91 (06) : 1255 - +
  • [2] Impact of Bariatric Surgery on Metabolic and Lithogenic Risk Factors in Patients with Morbid Obesity
    San Roman, Sofia
    Bruno, Gustavo
    Fernandez Talice, Lucia
    Ottati, Gabriela
    Portas, Pilar
    Garau, Mariela
    Noboa, Oscar A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [3] Preparation for bariatric surgery for patients with morbid obesity
    Sierzantowicz, Regina
    Hady, Hady Razak
    Kirpsza, Bozena
    Trochimowicz, Lech
    Dadan, Jacek
    PIELEGNIARSTWO CHIRURGICZNE I ANGIOLOGICZNE-SURGICAL AND VASCULAR NURSING, 2012, (03): : 105 - 108
  • [4] Bariatric Surgery for Morbid Obesity
    Mark J Monteforte
    Charles M Turkelson
    Obesity Surgery, 2000, 10 : 391 - 401
  • [5] Bariatric surgery for morbid obesity
    Monteforte, MJ
    Turkelson, CM
    OBESITY SURGERY, 2000, 10 (05) : 391 - 401
  • [6] Bariatric surgery for morbid obesity
    DeMaria, Eric J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (21): : 2176 - 2183
  • [7] Bariatric surgery for morbid obesity
    Chen, Rui
    Takahashi, Takashi
    Kanda, Tsugiyasu
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (11): : 1159 - 1159
  • [8] Bariatric surgery - Surgery for weight control in patients with morbid obesity
    Balsiger, BM
    Murr, MM
    Poggio, JL
    Sarr, MG
    MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (02) : 477 - +
  • [9] Vitamin D Deficiency in Patients with Morbid Obesity before and after Metabolic Bariatric Surgery
    Musella, Mario
    Berardi, Giovanna
    Vitiello, Antonio
    Dayan, Danit
    Schiavone, Vincenzo
    Franzese, Antonio
    Abu-Abeid, Adam
    NUTRIENTS, 2022, 14 (16)
  • [10] Impact of Bariatric Surgery on the Saliva of Patients with Morbid Obesity
    Hashizume, Lina N.
    Bastos, Lucelen F.
    Cardozo, Debora D.
    Hilgert, Juliana B.
    Hugo, Fernando N.
    Stein, Airton T.
    Souto, Katia E. P.
    Meinhardt, Nelson G.
    OBESITY SURGERY, 2015, 25 (08) : 1550 - 1555